Amsterdam

• Guanabenz in VWM: extension study Recruiting
  2024-518834-95-02 9 2025-12-08 Vanishing white matter
• Efficacy and Safety of Icotrokinra in Participants with Moderately to Severely Active Crohn’s Disease Recruiting
  2025-521382-27-00 10 2025-12-04 Moderately to Severely Active Crohn's Disease
• Efficacy and Safety of Icotrokinra in Adult and Adolescent Participants with Moderately to Severely Active Ulcerative Colitis Recruiting
  2025-521381-10-00 5 2025-12-03 Moderately to Severely Active Ulcerative Colitis
• A study to find out how EMPAgliflozin is tolerated and if it helps children and adolescents with chronic KIDNEY disease (EMPA-KIDNEY Kids) Recruiting
  2024-512577-27-00 5 2025-12-02 Chronic kidney disease in paediatric patients
• A Study to Learn About the Study Medicine Called PF-08046054/SGNPDL1V Versus Docetaxel in Adult Participants with Previously-treated Program … Recruiting
  2025-521281-97-00 5 2025-12-02 Non-Small Cell Lung Cancer (NSCLC)
• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis Recruiting
  2025-521242-26-00 4 2025-11-27 Moderately to Severely Active Ulcerative Colitis
• A clinical study of tulisokibart to treat radiographic axial spondyloarthritis (MK-7240-013) Recruiting
  2025-521059-21-00 4 2025-11-25 Radiographic axial spondyloarthritis (as known as ankylosing spondylit
• A Phase 1/2 Study of BMS-986482 Alone or Combination Therapy in Participants with Advanced Solid Tumors Recruiting
  2024-516602-28-00 7 2025-11-21 Advanced Solid Tumors
• A Phase 2 Study of CRD-4730 in CPVT Recruiting
  2024-515564-32-00 4 2025-11-20 Catecholaminergic Polymorphic Ventricular Tachycardia
• A trial to learn how safe AZD4063 is, how it moves throughout the body over time, and how it affects the levels of PLN mRNA in adults with d … Recruiting
  2025-522002-20-00 1 2025-11-20 PLN R14del Dilated Cardiomyopathy
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ANB033 Recruiting
  2024-520409-38-00 1 2025-11-14 Eosinophilic esophagitis (EoE)
• PROMOTE Recruiting
  2024-520351-24-00 6 2025-11-13 Acute coronary syndrome and chronic coronary syndrome
• A Study in TKI-naive Patients With Advanced ALK-Positive NSCLC ( ALKAZAR ) Recruiting
  2024-517553-26-00 5 2025-11-12 Advanced ALK-positive non-small cell lung cancer (NSCLC)
• A Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting
  2024-518008-33-00 5 2025-11-12 Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)
• Early treatment of irregular heartbeat (atrial fibrillation) to prevent a recurrent stroke Recruiting
  2025-521260-35-00 6 2025-11-07 acute ischemic stroke and atrial fibrillation (AF)
• A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants with PD-1 … Recruiting
  2023-506384-34-00 7 2025-11-05 Locally advanced or metastatic urothelial carcinoma
• TransBronchial Needle injection of Tremelimumab in early-stage NSCLC patients (TALENT) Recruiting
  2024-511878-67-00 9 2025-11-03 Non small cell lung cancer
• Sleeping through Menopause Recruiting
  2024-512071-12-00 6 2025-10-29 Insomnia
• A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease Recruiting
  2025-520747-32-00 5 2025-10-29 Mild to moderate Alzheimer’s Disease
• Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI … Recruiting
  2024-514693-47-01 11 2025-10-28 EGFR mutated locally advanced or metastatic non-small cell lung cancer
• Soothing Pain After ChEmotherapy: Psilocybin As INtervention (SPACE-PAIN) — a randomized controlled pilot trial Recruiting
  2024-516936-93-02 4 2025-10-28 chemotherapy-induced peripheral neuropathy, chronic neuropathic pain
• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin i … Recruiting
  2024-518365-10-00 5 2025-10-28 Previously Untreated Advanced or Metastatic Non-Squamous Non−Small Cel
• STOP-RIO: A randomized controlled non-inferiority trial to test the safety of discontinuation of riociguat after balloon pulmonary angioplas … Recruiting
  2024-519225-38-00 11 2025-10-28 Chronic thromboembolic pulmonary hypertension (CTEPH)
• An Open-label, Phase 4 Study of Nirogacestat in Adult Premenopausal Females with Desmoid Tumor/Aggressive Fibromatosis (DT/AF). Recruiting
  2024-515215-21-00 6 2025-10-24 DESMOID TUMOURS/AGGRESSIVE FIBROMATOSIS (DT/AF)

Showing 265–288 of 1,112 trials